Insulet Research Development vs Operating Income Analysis

PODD Stock

USD 262.00 4.58 1.72%

Insulet financial indicator trend analysis is infinitely more than just investigating Insulet recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Insulet is a good investment. Please check the relationship between Insulet Research Development and its Operating Income accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.

Research Development vs Operating Income

Research Development vs Operating Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Insulet Research Development account and Operating Income. At this time, the significance of the direction appears to have strong relationship.

The correlation between Insulet's Research Development and Operating Income is 0.76. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Operating Income in the same time period over historical financial statements of Insulet, assuming nothing else is changed. The correlation between historical values of Insulet's Research Development and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Insulet are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Research Development i.e., Insulet's Research Development and Operating Income go up and down completely randomly.

Correlation Coefficient

0.76

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Research Development

Operating Income

Operating Income is the amount of profit realized from Insulet operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Insulet is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most indicators from Insulet's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Insulet current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.At present, Insulet's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 10.3 B, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.17.

	2021	2022	2023	2024 (projected)
Interest Income	500K	9.8M	28.9M	30.3M
Tax Provision	3.7M	5.2M	9.1M	9.6M

Interest Income Tax Provision

Insulet fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Net Debt	Cash	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Short Term Debt	Property Plant And Equipment Net	Current Deferred Revenue	Retained Earnings	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Common Stock Total Equity	Non Current Liabilities Total	Other Current Assets	Property Plant And Equipment Gross	Common Stock	Other Liab
Total Assets		0.96	0.89	0.92	0.5	0.92	0.51	0.65	0.99	0.99	0.99	0.94	0.97	0.03	0.99	0.83	-0.08	0.51	0.99	0.92	0.91	0.99	0.98	0.98	0.75	0.69
Total Stockholder Equity	0.96		0.76	0.91	0.42	0.91	0.45	0.63	0.92	0.97	0.92	0.9	0.92	0.0	0.93	0.79	0.0	0.4	0.92	0.85	0.84	0.91	0.96	0.93	0.66	0.69
Net Debt	0.89	0.76		0.68	0.41	0.68	0.43	0.44	0.92	0.85	0.91	0.92	0.92	-0.03	0.92	0.84	-0.01	0.39	0.94	0.88	0.82	0.91	0.89	0.94	0.66	0.42
Cash	0.92	0.91	0.68		0.59	1.0	0.57	0.78	0.91	0.94	0.92	0.76	0.81	0.12	0.89	0.63	-0.27	0.67	0.87	0.79	0.86	0.92	0.85	0.85	0.77	0.87
Other Assets	0.5	0.42	0.41	0.59		0.59	0.35	0.53	0.52	0.5	0.54	0.33	0.37	-0.13	0.51	0.32	-0.22	0.54	0.49	0.67	0.4	0.56	0.42	0.49	0.53	0.63
Cash And Short Term Investments	0.92	0.91	0.68	1.0	0.59		0.57	0.78	0.91	0.94	0.92	0.76	0.81	0.12	0.89	0.63	-0.27	0.67	0.87	0.79	0.86	0.92	0.85	0.85	0.77	0.87
Common Stock Shares Outstanding	0.51	0.45	0.43	0.57	0.35	0.57		0.91	0.52	0.51	0.54	0.39	0.43	0.09	0.48	0.33	-0.78	0.59	0.5	0.42	0.72	0.53	0.41	0.44	0.87	0.62
Other Stockholder Equity	0.65	0.63	0.44	0.78	0.53	0.78	0.91		0.64	0.67	0.67	0.46	0.51	0.17	0.6	0.34	-0.69	0.69	0.61	0.52	0.74	0.66	0.53	0.55	0.88	0.86
Total Liab	0.99	0.92	0.92	0.91	0.52	0.91	0.52	0.64		0.98	1.0	0.94	0.96	0.04	0.99	0.83	-0.11	0.54	0.99	0.92	0.91	1.0	0.97	0.98	0.76	0.68
Total Current Assets	0.99	0.97	0.85	0.94	0.5	0.94	0.51	0.67	0.98		0.98	0.93	0.95	0.04	0.97	0.81	-0.09	0.5	0.96	0.9	0.9	0.98	0.97	0.97	0.74	0.72
Short Long Term Debt Total	0.99	0.92	0.91	0.92	0.54	0.92	0.54	0.67	1.0	0.98		0.92	0.94	0.05	0.99	0.8	-0.15	0.58	0.99	0.91	0.92	1.0	0.95	0.98	0.78	0.71
Other Current Liab	0.94	0.9	0.92	0.76	0.33	0.76	0.39	0.46	0.94	0.93	0.92		1.0	-0.01	0.93	0.94	0.09	0.26	0.95	0.91	0.83	0.91	0.98	0.97	0.61	0.44
Total Current Liabilities	0.97	0.92	0.92	0.81	0.37	0.81	0.43	0.51	0.96	0.95	0.94	1.0		-0.02	0.96	0.93	0.05	0.34	0.97	0.92	0.87	0.94	0.99	0.98	0.66	0.5
Short Term Debt	0.03	0.0	-0.03	0.12	-0.13	0.12	0.09	0.17	0.04	0.04	0.05	-0.01	-0.02		-0.06	-0.03	-0.23	0.03	0.0	-0.1	-0.03	0.05	-0.06	-0.06	-0.03	0.02
Property Plant And Equipment Net	0.99	0.93	0.92	0.89	0.51	0.89	0.48	0.6	0.99	0.97	0.99	0.93	0.96	-0.06		0.82	-0.05	0.55	0.99	0.91	0.91	0.99	0.97	0.99	0.75	0.68
Current Deferred Revenue	0.83	0.79	0.84	0.63	0.32	0.63	0.33	0.34	0.83	0.81	0.8	0.94	0.93	-0.03	0.82		0.16	0.13	0.85	0.89	0.73	0.79	0.88	0.87	0.52	0.26
Retained Earnings	-0.08	0.0	-0.01	-0.27	-0.22	-0.27	-0.78	-0.69	-0.11	-0.09	-0.15	0.09	0.05	-0.23	-0.05	0.16		-0.58	-0.07	0.03	-0.35	-0.14	0.07	0.02	-0.51	-0.45
Accounts Payable	0.51	0.4	0.39	0.67	0.54	0.67	0.59	0.69	0.54	0.5	0.58	0.26	0.34	0.03	0.55	0.13	-0.58		0.51	0.38	0.66	0.59	0.37	0.43	0.76	0.79
Non Current Assets Total	0.99	0.92	0.94	0.87	0.49	0.87	0.5	0.61	0.99	0.96	0.99	0.95	0.97	0.0	0.99	0.85	-0.07	0.51		0.92	0.9	0.98	0.97	0.99	0.74	0.64
Non Currrent Assets Other	0.92	0.85	0.88	0.79	0.67	0.79	0.42	0.52	0.92	0.9	0.91	0.91	0.92	-0.1	0.91	0.89	0.03	0.38	0.92		0.79	0.91	0.92	0.94	0.67	0.53
Common Stock Total Equity	0.91	0.84	0.82	0.86	0.4	0.86	0.72	0.74	0.91	0.9	0.92	0.83	0.87	-0.03	0.91	0.73	-0.35	0.66	0.9	0.79		0.91	0.87	0.88	0.88	0.67
Non Current Liabilities Total	0.99	0.91	0.91	0.92	0.56	0.92	0.53	0.66	1.0	0.98	1.0	0.91	0.94	0.05	0.99	0.79	-0.14	0.59	0.98	0.91	0.91		0.95	0.97	0.78	0.72
Other Current Assets	0.98	0.96	0.89	0.85	0.42	0.85	0.41	0.53	0.97	0.97	0.95	0.98	0.99	-0.06	0.97	0.88	0.07	0.37	0.97	0.92	0.87	0.95		0.99	0.67	0.58
Property Plant And Equipment Gross	0.98	0.93	0.94	0.85	0.49	0.85	0.44	0.55	0.98	0.97	0.98	0.97	0.98	-0.06	0.99	0.87	0.02	0.43	0.99	0.94	0.88	0.97	0.99		0.7	0.6
Common Stock	0.75	0.66	0.66	0.77	0.53	0.77	0.87	0.88	0.76	0.74	0.78	0.61	0.66	-0.03	0.75	0.52	-0.51	0.76	0.74	0.67	0.88	0.78	0.67	0.7		0.76
Other Liab	0.69	0.69	0.42	0.87	0.63	0.87	0.62	0.86	0.68	0.72	0.71	0.44	0.5	0.02	0.68	0.26	-0.45	0.79	0.64	0.53	0.67	0.72	0.58	0.6	0.76

Click cells to compare fundamentals

Insulet Account Relationship Matchups

Insulet fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.1B	1.9B	2.0B	2.3B	2.6B	2.7B
Total Stockholder Equity	75.9M	603.6M	556.3M	476.4M	732.7M	769.3M
Net Debt	511.8M	96.1M	457.2M	727.1M	711.6M	747.2M
Cash	376.1M	947.6M	791.6M	674.7M	704.2M	739.4M
Other Assets	25M	79M	106.1M	147.1M	1.0	0.95
Cash And Short Term Investments	376.1M	947.6M	791.6M	674.7M	704.2M	739.4M
Common Stock Shares Outstanding	62.3M	65.9M	68.6M	69.9M	73.6M	44.7M
Liabilities And Stockholders Equity	1.1B	1.9B	2.0B	2.3B	2.6B	2.7B
Other Stockholder Equity	749M	1.3B	1.2B	1.0B	1.1B	620.4M
Total Liab	1.1B	1.3B	1.5B	1.8B	1.9B	1.9B
Total Current Assets	591M	1.2B	1.3B	1.3B	1.6B	1.7B
Short Long Term Debt Total	891.5M	1.1B	1.3B	1.4B	1.4B	1.5B
Other Current Liab	96.4M	132.7M	162.5M	306.4M	379.1M	398.1M
Total Current Liabilities	157.7M	207.8M	228.8M	364.7M	451.2M	473.8M
Property Plant And Equipment Net	399.4M	478.7M	536.5M	599.9M	692.8M	727.4M
Current Deferred Revenue	3.2M	5.4M	3.5M	16.1M	15.4M	16.2M
Retained Earnings	(672M)	(666.3M)	(649.5M)	(584.3M)	(378M)	(396.9M)
Accounts Payable	54.5M	54.1M	37.7M	30.8M	19.2M	19.7M
Non Current Assets Total	551.9M	624.2M	719M	937.1M	1.0B	1.1B
Non Currrent Assets Other	41.1M	77M	106.1M	210M	135.5M	142.3M
Non Current Liabilities Total	909.3M	1.1B	1.3B	1.4B	1.4B	1.5B
Other Current Assets	31.1M	63M	74M	86.9M	116.4M	122.2M
Property Plant And Equipment Gross	399.4M	478.7M	715.7M	834.6M	958.1M	1.0B
Accumulated Other Comprehensive Income	(1.2M)	5.5M	(2.2M)	20M	8M	8.4M
Other Liab	7M	17.8M	14.9M	8.3M	9.5M	5.4M
Long Term Debt	887.9M	1.0B	1.2B	1.4B	1.4B	1.4B
Net Receivables	82.8M	83.8M	161M	205.6M	359.7M	377.7M
Short Term Investments	175.0M	162.4M	40.4M	50.8M	26.9M	25.6M
Inventory	101M	154.3M	303.2M	346.8M	402.6M	422.7M
Property Plant Equipment	399.4M	478.7M	536.5M	599.9M	689.9M	724.4M
Net Tangible Assets	22.9M	535.1M	479.9M	349.2M	401.6M	421.7M
Good Will	39.8M	39.6M	39.8M	51.7M	59.5M	44.1M
Retained Earnings Total Equity	(672M)	(666.3M)	(649.5M)	(584.3M)	(525.9M)	(552.2M)
Long Term Debt Total	887.9M	1.0B	1.2B	1.4B	1.6B	1.7B
Capital Surpluse	749M	1.3B	1.2B	1.0B	1.2B	899.1M
Deferred Long Term Liab	19.9M	21.9M	26.1M	31.3M	36.0M	37.8M
Non Current Liabilities Other	21.4M	17.8M	14.9M	35.7M	37.9M	39.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Insulet is a strong investment it is important to analyze Insulet's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insulet's future performance. For an informed investment choice regarding Insulet Stock, refer to the following important reports:

How To Invest In Insulet

Details

Is Insulet Stock a good investment?

Details

What is Insulet's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.

You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.46

Earnings Share

5.86

Revenue Per Share

28.341

Quarterly Revenue Growth

0.257

Return On Assets

0.0757

The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Insulet Research Development vs Operating Income Analysis

Research Development vs Operating Income

Research Development vs Operating Income Correlation Analysis

Correlation Coefficient

Research Development

Operating Income

Insulet fundamental ratios Correlations

Insulet Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Insulet fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Short Long Term Debt Total	+ 1.0	Total Liab
Non Current Liabilities Total	+ 1.0	Total Liab
Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Total Current Liabilities	+ 1.0	Other Current Liab
Total Liab	+ 0.99	Total Assets

Retained Earnings	- 0.78	Common Stock Shares Outstanding
Retained Earnings	- 0.69	Other Stockholder Equity
Accounts Payable	- 0.58	Retained Earnings
Common Stock	- 0.51	Retained Earnings
Other Liab	- 0.45	Retained Earnings
Common Stock Total Equity	- 0.35	Retained Earnings